MeSH D006561 - herpes simplex
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006561:
Herpes simplex
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Acyclovir | Acyclovir | 1997-04-22 | |||
| Famciclovir | Famciclovir | 2007-08-24 | ||||
| Valacyclovir | Valacyclovir | 2010-05-24 | ||||
| Padagis | Acyclovir | Acyclovir | 2019-02-20 | |||
| Taro Pharmaceutical | Acyclovir | Acyclovir | 2016-12-21 | |||
| Glenmark Pharmaceuticals | Acyclovir | Acyclovir | 2017-07-31 | |||
| Mylan | Acyclovir | Acyclovir | 1998-04-13 | |||
| Valacyclovir | Valacyclovir | 2010-05-24 | ||||
| Acyclovir | Zovirax | 1985-01-25 | ||||
| NATCO Pharma | Famciclovir | Famciclovir | 2011-03-24 | |||
| Xiromed | Acyclovir | Acyclovir | 2020-01-29 | |||
| GSK | Valacyclovir | Valtrex | 1995-06-23 | |||
| Acyclovir | Zovirax | 1982-10-22 | ||||
| Cipla | Acyclovir | Acyclovir | 2019-01-18 | |||
| Famciclovir | Famciclovir | 2011-03-21 | ||||
| Valacyclovir | Valacyclovir | 2010-05-24 | ||||
| Sandoz | Valacyclovir | Valacyclovir | 2010-05-24 |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
50%3/6
Phase 2
75%3/4
Phase 3
85%11/13
Approved: 6Overall Success rate: 32%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use